Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic

6 months ago 312

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic and Wegovy.